EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Postoperative Radiation With or Without Concurrent Chemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma With Multiple Intermediate Risks: A Propensity Score‐Matched Study

Thun Leewiboonsilp, Chuleepon Jianpinijnan, Nintita Sripaiboonkij Thokanit, Poompis Pattaranutaporn, Nuttapong Ngamphaiboon iD

Cancer Medicine · 2025

DOI: 10.1002/cam4.70746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Thun Leewiboonsilp und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Chemoradiotherapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Systems Research Institute, National Science Research Fund (NSRF) via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation, Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The benefit of postoperative chemoradiotherapy (CRT) over radiotherapy (RT) alone remains unclear for resected locally advanced head and neck squamous cell carcinoma (LA‐HNSCC) patients with intermediate risk(s) such as pT3 or pT4 primary, pN2 or pN3 nodal disease, nodal disease in levels IV or V, perineural invasion (PNI), and lymphovascular invasion (LVI). This study aims to evaluate the benefits of postoperative CRT in patients with multiple intermediate risks.

Method

LA‐HNSCC patients who underwent curative surgery with intermediate risk at our institution were identified. A propensity score‐matched (PSM) method was performed using treatment, sex, age, AJCC staging, LVI, and PNI as covariates.

Result

A total of 162 eligible patients were identified. After PSM, 48 patients were classified into CRT and RT groups, respectively. Baseline characteristics and treatment were well balanced. In the CRT group, most patients received cisplatin‐CRT (67%). Patients with 1, 2, and ≥ 3 intermediate risk factors exhibited significantly different event‐free survival (EFS) (7.2 vs. 3.8 vs. 1.9 years; p = 0.007), with a trend towards differences in overall survival (OS) ( p = 0.068). The median OS of the postoperative RT and CRT groups was not significantly different (4.5 vs. 5.0 years; p = 0.950). Similarly, the median EFS was not significantly different ( p = 0.634). No EFS and OS benefits were demonstrated in patients with ≥ 2 intermediate risk factors treated with CRT compared to RT alone.

Conclusion

In our PSM study, LA‐HNSCC patients with intermediate risk(s) did not benefit from postoperative CRT compared to RT alone. Although patients with multiple intermediate risks had significantly worse survivals, postoperative CRT did not improve OS and EFS. The results of this study may support avoiding unnecessary acute and late toxicity associated with adding chemotherapy to postoperative RT in patients with intermediate risk(s).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsChemoradiotherapyHumansMaleFemaleMiddle AgedPropensity ScoreAgedRetrospective StudiesRisk FactorsAdultNeoplasm Staging

Stichwörter der Autor:innen

CRTHNSCCadjuvantchemoradiotherapyhead and neck squamous cell carcinomaintermediate risklocally advancedpostoperativeradiationradiotherapy

Autor:innen und Institutionen

  • Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Ramathibodi Comprehensive Cancer Center, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

ORCID-Profile: Nuttapong Ngamphaiboon

Förderung

  • Health Systems Research Institute
  • National Science Research Fund (NSRF) via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation
  • Mahidol University
  • National Research Council of Thailand

Zitieren

APA

Leewiboonsilp, T., Jianpinijnan, C., Thokanit, N. S., Pattaranutaporn, P., & Ngamphaiboon, N. (2025). Postoperative Radiation With or Without Concurrent Chemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma With Multiple Intermediate Risks: A Propensity Score‐Matched Study. Cancer Medicine. https://doi.org/10.1002/cam4.70746

Vancouver

Leewiboonsilp T, Jianpinijnan C, Thokanit NS, Pattaranutaporn P, Ngamphaiboon N. Postoperative Radiation With or Without Concurrent Chemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma With Multiple Intermediate Risks: A Propensity Score‐Matched Study. Cancer Medicine. 2025. doi:10.1002/cam4.70746

BibTeX
@article{Leewiboonsilp2025,
  author = {Leewiboonsilp, Thun and Jianpinijnan, Chuleepon and Thokanit, Nintita Sripaiboonkij and Pattaranutaporn, Poompis and Ngamphaiboon, Nuttapong},
  title = {Postoperative Radiation With or Without Concurrent Chemotherapy for Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma With Multiple Intermediate Risks: A Propensity Score‐Matched Study},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.70746}
}
Kostenlos starten →